Results 161 to 170 of about 1,734,152 (292)

Greater Mediterranean Diet Adherence Is Associated with Lower Odds of Chronic Migraine: A Retrospective Observational Study. [PDF]

Nutrients
Alis C, Uludüz E, Eyüpoğlu S, İskender M, Öztornacı O, Özge A, Uludüz D.   +6 more
europepmc   +1 more source

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations

, 2017
Piero Barbanti,1 Patrizia Ferroni2 1Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, 2Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, IRCCS San Raffaele Pisana, Rome, Italy ...
Ferroni P, Barbanti P
core  

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source

Interictal and Ictal Cognitive Performance in Episodic and Chronic Migraine. [PDF]

Eur J Neurol
Kizilkilic EK, Kılboz BB, Yaman SÜ.
europepmc   +1 more source

Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0

BJU International, EarlyView.
Objective To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8–20 mm in diameter on operative time, surgeon workload, and retropulsion. Subjects/Patients and Methods In our multicentre, randomised, double‐blind clinical trial, patients were randomised 1:
Kimberly A. Maciolek, Naren Nimmagadda, Aaron X. Lee, Amy M. Reed, Ryan S. Hsi, Tatsuki Koyama, Connor M. Forbes, Matthew S. Lee, Cyrus Chehroudi, Ezra J. Margolin, Ben H. Chew, Seth K. Bechis, Mitchell R. Humphreys, Michael E. Lipkin, Manoj Monga, Ojas Shah, Karen L. Stern, Roger L. Sur, Sri Sivalingam, Nicole L. Miller   +19 more
wiley   +1 more source

Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine. [PDF]

J Clin Med
Lin CF, Chung CC, Chen JH, Chi NF, Hu CJ, Huang HE, Chen CC, Yeh TH, Wei JC, Lee HH.   +9 more
europepmc   +1 more source

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice

British Journal of Pharmacology, EarlyView.
Background and Purpose Migraine is a neurovascular disorder largely mediated by calcitonin gene‐related peptide (CGRP). This study explores the role of the nociceptin/orphanin FQ (N/OFQ)–N/OFQ receptor (NOP) system in CGRP‐induced periorbital mechanical allodynia (PMA) in mice.
Chiara Sturaro, Pietro Pola, Michela Argentieri, Alessia Frezza, Matilde Marini, Francesco De Logu, Valentina Albanese, Marie Soukupova, Davide Malfacini, Nurulain T. Zaveri, Romina Nassini, Dane D. Jensen, Pierangelo Geppetti, Girolamo Calò, Chiara Ruzza   +14 more
wiley   +1 more source

Migrainous Thoracalgia in a Patient with Chronic Migraine and Coronary Vasospasm: A Case Report. [PDF]

Int Med Case Rep J
Zeldich D, Wang VS, David C, Lauritsen C, Ceriani C.   +4 more
europepmc   +1 more source

Chronic migraine [PDF]

Neurologie pro praxi, 2019
openaire   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source